Effectiveness, tolerability and safety of opicapone in fluctuating Parkinson's disease

被引：0
|
作者：
Marti-Andres, G. [1 ]
Armengou, L. [1 ]
Esparragosa, I. [1 ]
Toledano Illan, C. [1 ]
Valenti, R. [1 ]
Luquin, R. [1 ]
机构：
[1] Clin Univ Navarra, Neurol, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1184
引用
收藏
页码：633 / 634
页数：2
相关论文
共 50 条
  • [41] COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease
    Lee, MS
    Kim, HS
    Cho, EK
    Lim, JH
    Rinne, JO
    NEUROLOGY, 2002, 58 (04) : 564 - 567
  • [42] Safety and tolerability of opicapone in Parkinson's disease (PD): from early-stage (EPSILON study) to late-stage (BIPARK studies)
    Cordeiro, G.
    Peixoto, I.
    Gama, H.
    Magalhaes, L.
    Moreira, J.
    Rocha, J. -F.
    Holenz, J.
    MOVEMENT DISORDERS, 2024, 39 : S335 - S336
  • [43] Opicapone Effect on Sleep Disorders in Fluctuating Parkinson's disease (PD) Patients: Findings from the OASIS Trial
    Ferreira, J.
    Gago, M.
    Costa, R.
    Fonesca, M.
    Almeida, J.
    Rocha, J.
    Holenz, J.
    Trenkwalder, C.
    MOVEMENT DISORDERS, 2024, 39 : S305 - S306
  • [44] Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease
    Ondo, W
    Hunter, C
    Almaguer, M
    Gancher, S
    Jankovic, J
    CLINICAL NEUROPHARMACOLOGY, 1999, 22 (01) : 1 - 4
  • [45] Opicapone in Parkinson’s disease: a profile of its use
    Scott L.J.
    Drugs & Therapy Perspectives, 2017, 33 (7) : 303 - 310
  • [46] Addition of Opicapone to Safinamide in Parkinson's Disease patients
    Russo, M.
    Carrarini, C.
    Dono, F.
    Di Pietro, M.
    Rispoli, M.
    Ferri, L.
    Onofrj, M.
    MOVEMENT DISORDERS, 2019, 34 : S80 - S80
  • [47] Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naive Parkinson's disease patients recently diagnosed with motor fluctuations
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Gama, H.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S461 - S462
  • [48] Opicapone (Ongentys) - A COMT Inhibitor for Parkinson's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1615): : 3 - 5
  • [49] EFFICACY AND SAFETY/TOLERABILITY OF OPICAPONE IN CATECHOL-O-METHYLTRANSFERASE INHIBITOR-NAIVE PARKINSON'S DISEASE PATIENTS RECENTLY DIAGNOSED WITH MOTOR FLUCTUATIONS
    Lees, A.
    Ferreira, J. J.
    Poewe, W.
    Gama, H.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E57 - E57
  • [50] EFFICACY AND SAFETY OF OPICAPONE IN PATIENTS OVER 70 YEARS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS
    Lees, A.
    Ferreira, J.
    Costa, R.
    Santos, A.
    Rocha, J.
    Soares-Da-Silva, P.
    AGE AND AGEING, 2019, 48
12345